Uncategorized

India will produce about 300 million doses of Russia’s Sputnik V coronavirus vaccines next year Head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said that production of Sputnik V began in other countries, in particular in India, Korea, Brazil, and China.The Head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said in an interview with Rossiya 24 TV channel.

“In India, we have agreements with four large manufacturers. India will produce about 300 million doses or more of the vaccine for us next year,” he said.

Sputnik V is already under phase two/three trials in India over 22, 000 have been given the first dose and 19,000 has already received first and second trials. India is the largest vaccine maker , vaccine production and pharmaceutical industry in the world. 

Dmitriev noted that out of 110 production sites that negotiated production of Sputnik V, RDIF chose 10 that meet its requirements. “The Russian Sputnik V will be actively produced in the world and we see that this is built on a safe platform based on the human adenovirus,” Dmitriev said.

According to the Union Health Ministry, India’s Total Recovered Cases cross the landmark peak of 95 lakhs and 95.40% Recovery Rate amongst the highest in the world.

India has reported 22,889 new COVID-19 cases, India’s total cases rise up to 99,79,447. The death cases reported in the last 24 hours are 338, the total number of deaths reported from the time of the outbreak in India are 1,44,789.

The total active COVID-19 cases are 3,13,831.

Total number samples tested-ICMR

The total number of COVID-19 samples tested in 24 hours for COVID-19 are 11,13,406 and samples tested for COVID-19 from the time of the outbreak are 15,89,18,646.

According to the Union Health Ministry, India has reported 22,889 new COVID-19 cases, India’s total cases rise up to 99,79,447. The death cases reported in the last 24 hours are 338, the total number of deaths reported from the time of the outbreak in India are 1,44,789.

The total active COVID-19 cases are 3,13,831.

Total number samples tested-ICMR

The total number of COVID-19 samples tested in 24 hours for COVID-19 are 11,13,406 and samples tested for COVID-19 from the time of the outbreak are 15,89,18,646.

The Maharashtra government has decided to reimburse all the medical expenses spent by the government employees for themselves and for their families, “Maharashtra government has decided to reimburse the medical expenses of COVID-19 treatment of govt employees & their family members. The order will be effective from September 2, 2020,” the statement given by the Maharashtra Health Minister Rajesh Tope on ANI

The Ministry of AYUSH and Ministry of Youth Affiars and Sports announced the formal recognition of Yogasana as a COMPETITIVE  SPORT.

Union Minister of State for AYUSH Shripad Naik, and the Union Minister of State for Youth Affairs &Sports Kiren Rijjju announced this at a joint press conference. During the press conference, the Union Minister of State fro Ayush Shripad Naik said, “They are still being conducted today at multiple levels , but a strong and sustainable structure to impact national visibility to the competitions is yet to emerge.

“The Government decision to recognise Yogasana as a competitive sport comes after 3-4 years of wide consultations with the stakeholders of the Yoga sector.”he further added

The Union Minister of State for Youth Affairs &SportsKiren Rijjju , said “The competitions that will arise out of the recognition of Yogasana as a sport will enhance interest in Yoga among people around the globe.”

“Yogasana will be introduced as a competitive sport in Khelo India, National and University Games.” he further added

According to the Union Ministry of Health and Family Welfare, India has reported 24,010 new COVID-19 cases in the last 24 hours. India has reported 99,56,558 total cases from the time of the outbreak and the total deaths reported so far are 1,44,451.

Total active COVID-19 cases in India are 3,22,366. The total number of deaths reported in India is 355.

Total number of tests done – ICMR

The total number of 15,78,05,240 samples tested for COVID-19 till 16th December and 11,58,960 samples have been tested yesterday in a single day.

The Bharat BioTech’s Phase -1 trials shown promising results vaccine was well tolerated in all groups. The COVAXIN is India’s first indigenous vaccine. The phase-1 trials was conducted on 375 volunteers. “The vaccine was well tolerated in all dose groups with no vaccine-related serious adverse events. Interim findings from phase 1 trial of Covaxin: After 1st vaccination, local & systemic adverse events were predominantly mild/moderate in severity & resolved rapidly, without prescribed medication. The most common adverse event was pain at the injection site which resolved spontaneously.” Bharat BioTech said in a research papers

The company has said the majority of mild symptoms have been observed during the study but no major serious adverse effect have been reported.

“Only one serious adverse event was reported that was unrelated to the vaccination,” the company said in the research papers published on https://www.medrxiv.org/content/10.1101/2020.12.11.20210419v1.full.pdf

Over 100,000 people in Saudi Arabia have registered for the coronavirus vaccination on the opening day of vaccination, the Saudi Health Ministry said

“Up until now, 100,546 people have signed up through the application on…smartphones to receive the coronavirus vaccine,” the ministry said in a statement.

The vaccine will be given first to those who are above 65 years or those who have chronic diseases. The Saudi Food and Drug Authority has approved last week the registration and use of a vaccine produced by US drug makers Pfizer & with its German partner BioNTech. The U.K and U.S have already started the vaccination.

The Federation of residents doctors’ association (FORDA) writes a letter to the National Medical Commission(NMC) regarding the Fee structures and service bonds in medical education by several states.

According to the latest updates by State the government of Haryana has raised fee for MBBS course up to 10 lakh per annum. The Government of Punjab had also hiked fee for MBBS course up to 7.81 lakh per annum.

On the other hand, the Government of Uttar Pradesh has announced Bond of 10 years or in-service candidates for P.G. seats. The penalty for withdrawal would be 1.crore.

“This step will not only discourage aspirants from opting for P.G.seats, in the long run it may pose a risk for further of quality for healthcare force,” says FORDA statement

Nurses at AIIMS call off their strike after a long meeting with AIIMS administration. The AIIMS administration has given an assurance about reaching out at some solution as soon as possible.

The nurses have called off their strike and joined their duties,”said Dr Randeep Guleria, AIIMS ,Director

The 5000, nurses of All India Institute of medical sciences (AIIMS) have gone for an indefinite strike on Monday for their 23 demands including with those of pending Sixth Central Pay Commission (CPC).